StockData
COMPASS Pathways plc logo

COMPASS Pathways plc (CMPS) stock

CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 1/30
$9.01−0.11 (-1.21%)

Close on Nov 13, 2026Market cap $1.25BP/E –Yield –

COMPASS Pathways cash

Cash and short-term investments held at the end of each period.

COMPASS Pathways's cash was $433.30M at Jun 30, 2026. For fiscal 2025 it was $149.61M, down 9.6% from the year before. The highest annual figure on record is $273.24M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$149.61M-9.6%
FY2024Dec 31, 2024$165.47M-25.0%
FY2023Dec 31, 2023$220.64M+53.9%
FY2022Dec 31, 2022$143.38M-47.5%
FY2021Dec 31, 2021$273.24M+43.5%
FY2020Dec 31, 2020$190.36M+661.9%
FY2019Dec 31, 2019$24.98M+9.1%
FY2018Dec 31, 2018$22.91M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$433.30M+95.3%
Q1 FY2026Mar 31, 2026$466.01M+79.2%
Q4 FY2025Dec 31, 2025$149.61M-9.6%
Q3 FY2025Sep 30, 2025$185.94M-10.2%
Q2 FY2025Jun 30, 2025$221.88M-3.0%
Q1 FY2025Mar 31, 2025$260.11M-1.1%
Q4 FY2024Dec 31, 2024$165.47M-25.0%
Q3 FY2024Sep 30, 2024$206.95M-16.6%
Q2 FY2024Jun 30, 2024$228.63M+54.2%
Q1 FY2024Mar 31, 2024$262.89M+124.5%
Q4 FY2023Dec 31, 2023$220.64M+53.9%
Q3 FY2023Sep 30, 2023$248.04M+43.3%
Q2 FY2023Jun 30, 2023$148.23M-28.5%
Q1 FY2023Mar 31, 2023$117.10M-51.9%
Q4 FY2022Dec 31, 2022$143.38M-47.5%
Q3 FY2022Sep 30, 2022$173.08M-41.1%
Q2 FY2022Jun 30, 2022$207.18M-34.5%
Q1 FY2022Mar 31, 2022$243.68M+35.7%
Q4 FY2021Dec 31, 2021$273.24M+43.5%
Q3 FY2021Sep 30, 2021$293.96M+49.6%
Q2 FY2021Jun 30, 2021$316.33M+367.9%
Q1 FY2021Mar 31, 2021$179.52M+618.5%
Q4 FY2020Dec 31, 2020$190.36M+731.0%
Q3 FY2020Sep 30, 2020$196.51M–
Q2 FY2020Jun 30, 2020$67.61M–
Q4 FY2019Dec 31, 2019$24.98M–
Q4 FY2018Dec 31, 2018$22.91M–

More COMPASS Pathways figures

See a number that looks wrong?